DARS1 (Aspartyl-tRNA Synthetase 1) encodes the cytoplasmic aspartyl-tRNA synthetase (AspRS), an essential enzyme in protein synthesis that catalyzes the attachment of aspartic acid to its cognate tRNA. While primarily known for its fundamental role in translation, DARS1 has emerged as a significant player in neurodegeneration through both classical disease mechanisms involving tRNA charging defects and moonlighting functions in RNA processing, cell signaling, and immune regulation. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegenerative diseases.
| Symbol | DARS1 |
|---|---|
| Full Name | Aspartyl-tRNA Synthetase 1 |
| Chromosomal Location | 2q21.3 |
| NCBI Gene ID | [1655](https://www.ncbi.nlm.nih.gov/gene/1655) |
| OMIM | [615856](https://www.omim.org/entry/615856) |
| Ensembl ID | ENSG00000136444 |
| UniProt | [P14868](https://www.uniprot.org/uniprotkb/P14868/entry) |
| Associated Diseases | [Leukoencephalopathy with thalamus and brainstem involvement (LBSL)]((/diseases/leukoencephalopathy)), Neurodevelopmental Disorders, Charcot-Marie-Tooth Disease, [Parkinson's Disease](/diseases/parkinsons-disease), [Amyotrophic Lateral Sclerosis](/diseases/als) |
The DARS1 gene is located on chromosome 2q21.3 and consists of 18 exons spanning approximately 42 kb. The coding sequence encodes a 643 amino acid protein with a molecular weight of approximately 71 kDa. DARS1 belongs to class II aminoacyl-tRNA synthetases, characterized by three conserved sequence motifs that form the active site. The enzyme exists as a homodimer in solution, with dimerization required for full catalytic activity.
DARS1 is highly conserved across all kingdoms of life, and is distinct from the mitochondrial isoform DARS2.
DARS1 catalyzes the two-step aminoacylation reaction:
The enzyme exhibits high specificity for aspartic acid (L-isomer only), tRNA^Asp with correct anticodon (GTC), and proper CCA 3'-terminus.
DARS1 contributes to translational fidelity through proofreading of misactivated amino acids, rejection of non-cognate tRNAs, and monitoring of product release.
Beyond translation, DARS1 has several non-canonical functions:
DARS1 localizes to cytoplasm (primary location), nucleus (observed in some cell types), stress granules (upon cellular stress), and mitochondria (low-level).
DARS1 is ubiquitously expressed with highest levels in:
| Tissue | Expression Level |
|---|---|
| Brain | Very High |
| Spinal Cord | High |
| Heart | High |
| Liver | High |
| Kidney | Moderate-High |
Within the central nervous system, DARS1 is highly expressed in:
LBSL is a progressive white matter disorder caused by DARS1 mutations:
The mechanism involves impaired tRNA charging leading to reduced protein synthesis, vulnerability of white matter tracts, axonal dysfunction, and demyelination.
[1] and [2] provide comprehensive reviews of ARS-related diseases.
While more commonly associated with other ARS genes (especially GARS1, YARS1), DARS1 variants have been linked to CMT: peripheral neuropathy, primarily axonal CMT, and variable severity.
Emerging evidence links DARS1 to Parkinson's disease:
ARS genes, including DARS1, have been implicated in ALS:
DARS1 mutations can cause intellectual disability (variable severity), seizures, microcephaly, and developmental delay.
DARS1 interacts with:
Dars1 knockout is embryonic lethal around E7.5-E9.5 due to impaired protein synthesis and developmental arrest. Conditional knockouts in neurons survive but show deficits.
Sissler et al. Human mitochondrial aminoacyl-tRNA synthetases. Trends Cell Biol. 2017. ↩︎
Beyer et al. Aminoacyl-tRNA synthetases in neurodegeneration. Wiley Interdiscip Rev RNA. 2019. ↩︎